Bob Hopkins
Stock Analyst at B of A Securities
(0.30)
# 3,895
Out of 4,748 analysts
60
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Bob Hopkins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | $220 → $255 | $194.43 | +31.15% | 5 | Nov 20, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $90 → $100 | $103.04 | -2.95% | 5 | Oct 22, 2024 | |
| SGHT Sight Sciences | Downgrades: Underperform | $10 → $4.5 | $2.97 | +51.52% | 4 | Sep 13, 2023 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $48 | $71.57 | -32.93% | 1 | Oct 11, 2021 | |
| ABT Abbott Laboratories | Maintains: Buy | $133 | $128.79 | +3.27% | 2 | Aug 31, 2021 | |
| LUNG Pulmonx | Upgrades: Buy | $72 | $5.69 | +1,165.38% | 2 | Mar 10, 2021 | |
| ISRG Intuitive Surgical | Downgrades: Neutral | $242 → $253 | $580.18 | -56.34% | 7 | Sep 8, 2020 | |
| PEN Penumbra | Downgrades: Neutral | n/a | $269.14 | - | 2 | Sep 8, 2020 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $85 → $95 | $37.01 | +156.69% | 5 | May 22, 2020 | |
| JNJ Johnson & Johnson | Upgrades: Buy | n/a | $152.87 | - | 2 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $37 → $30 | $110.29 | -72.80% | 2 | Oct 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 → $74 | $5.21 | +1,320.35% | 5 | Aug 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $105 | $91.99 | +14.14% | 7 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $83 | $33.10 | +150.76% | 6 | May 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $260 | $248.49 | +4.63% | 4 | Jan 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $93.07 | - | 1 | Nov 10, 2017 |
Inspire Medical Systems
Nov 20, 2024
Upgrades: Buy
Price Target: $220 → $255
Current: $194.43
Upside: +31.15%
Boston Scientific
Oct 22, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $103.04
Upside: -2.95%
Sight Sciences
Sep 13, 2023
Downgrades: Underperform
Price Target: $10 → $4.5
Current: $2.97
Upside: +51.52%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $48
Current: $71.57
Upside: -32.93%
Abbott Laboratories
Aug 31, 2021
Maintains: Buy
Price Target: $133
Current: $128.79
Upside: +3.27%
Pulmonx
Mar 10, 2021
Upgrades: Buy
Price Target: $72
Current: $5.69
Upside: +1,165.38%
Intuitive Surgical
Sep 8, 2020
Downgrades: Neutral
Price Target: $242 → $253
Current: $580.18
Upside: -56.34%
Penumbra
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $269.14
Upside: -
Tandem Diabetes Care
May 22, 2020
Maintains: Neutral
Price Target: $85 → $95
Current: $37.01
Upside: +156.69%
Johnson & Johnson
Apr 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $152.87
Upside: -
Oct 31, 2019
Maintains: Underperform
Price Target: $37 → $30
Current: $110.29
Upside: -72.80%
Aug 9, 2019
Reiterates: Buy
Price Target: $70 → $74
Current: $5.21
Upside: +1,320.35%
Aug 22, 2018
Maintains: Buy
Price Target: $98 → $105
Current: $91.99
Upside: +14.14%
May 22, 2018
Maintains: Buy
Price Target: $73 → $83
Current: $33.10
Upside: +150.76%
Jan 19, 2018
Reinstates: Buy
Price Target: $260
Current: $248.49
Upside: +4.63%
Nov 10, 2017
Upgrades: Neutral
Price Target: n/a
Current: $93.07
Upside: -